The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
- PMID: 29042326
- PMCID: PMC5779616
- DOI: 10.1016/j.preteyeres.2017.10.002
The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
Abstract
Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding condition, retinitis pigmentosa (RP). Over 150 different mutations in rhodopsin have been identified and, collectively, they are the most common cause of autosomal dominant RP (adRP). Mutations in rhodopsin are also associated with dominant congenital stationary night blindness (adCSNB) and, less frequently, recessive RP (arRP). Recessive RP is usually associated with loss of rhodopsin function, whereas the dominant conditions are a consequence of gain of function and/or dominant negative activity. The in-depth characterisation of many rhodopsin mutations has revealed that there are distinct consequences on the protein structure and function associated with different mutations. Here we categorise rhodopsin mutations into seven discrete classes; with defects ranging from misfolding and disruption of proteostasis, through mislocalisation and disrupted intracellular traffic to instability and altered function. Rhodopsin adRP offers a unique paradigm to understand how disturbances in photoreceptor homeostasis can lead to neuronal cell death. Furthermore, a wide range of therapies have been tested in rhodopsin RP, from gene therapy and gene editing to pharmacological interventions. The understanding of the disease mechanisms associated with rhodopsin RP and the development of targeted therapies offer the potential of treatment for this currently untreatable neurodegeneration.
Keywords: CRISPR; Endocytosis; GPCR; Mutation; Neurodegeneration; Protein misfolding; Protein traffic; Proteostasis; Retinal dystrophy; Rhodopsin; Therapy.
Copyright © 2017. Published by Elsevier Ltd.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5779616/bin/emss-74536-f006.gif)
Similar articles
-
Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa.J Neurosci. 2017 Jan 25;37(4):1039-1054. doi: 10.1523/JNEUROSCI.1647-16.2016. J Neurosci. 2017. PMID: 28490005 Free PMC article.
-
Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.Trends Mol Med. 2005 Apr;11(4):177-85. doi: 10.1016/j.molmed.2005.02.007. Trends Mol Med. 2005. PMID: 15823756 Review.
-
Structural aspects of rod opsin and their implication in genetic diseases.Pflugers Arch. 2021 Sep;473(9):1339-1359. doi: 10.1007/s00424-021-02546-x. Epub 2021 Mar 16. Pflugers Arch. 2021. PMID: 33728518 Review.
-
Targeting the Proteostasis Network in Rhodopsin Retinitis Pigmentosa.Adv Exp Med Biol. 2016;854:479-84. doi: 10.1007/978-3-319-17121-0_64. Adv Exp Med Biol. 2016. PMID: 26427449 Free PMC article. Review.
-
Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3070-4. doi: 10.1073/pnas.92.7.3070. Proc Natl Acad Sci U S A. 1995. PMID: 7708777 Free PMC article.
Cited by
-
Mutant dominant-negative rhodopsin∆I256 causes protein aggregates degraded via ERAD and prevents normal rhodopsin from proper membrane trafficking.Front Mol Biosci. 2024 May 17;11:1369000. doi: 10.3389/fmolb.2024.1369000. eCollection 2024. Front Mol Biosci. 2024. PMID: 38828393 Free PMC article.
-
Dendrobium nobile Polysaccharide Attenuates Blue Light-Induced Injury in Retinal Cells and In Vivo in Drosophila.Antioxidants (Basel). 2024 May 14;13(5):603. doi: 10.3390/antiox13050603. Antioxidants (Basel). 2024. PMID: 38790708 Free PMC article.
-
Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis.Clin Cosmet Investig Dermatol. 2024 May 17;17:1133-1144. doi: 10.2147/CCID.S459070. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38774812 Free PMC article. Review.
-
The mechanism of genetically inherited night blindness.Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2408254121. doi: 10.1073/pnas.2408254121. Epub 2024 May 20. Proc Natl Acad Sci U S A. 2024. PMID: 38768361 No abstract available.
-
Dark continuous noise from mutant G90D-rhodopsin predominantly underlies congenital stationary night blindness.Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2404763121. doi: 10.1073/pnas.2404763121. Epub 2024 May 14. Proc Natl Acad Sci U S A. 2024. PMID: 38743626
References
-
- al-Jandal N, Farrar GJ, Kiang AS, Humphries MM, Bannon N, Findlay JB, Humphries P, Kenna PF. A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Human mutation. 1999;13:75–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials